18 results
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities;
changes
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Report of Foreign Private Issuer
8:15am
: Positive Regulatory Interaction, Buildup of Plant & Supply Chain Infrastructure On Schedule
Construction of Enlivex’s new cGMP Allocetra™ … occur if it receives applicable regulatory approvals. The Company’s efforts to establish supply chain infrastructure to support potential
424B5
jr9xodhy8 lmenfu
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
ll4awax
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.2
i509h yt4j
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
424B5
igr0 gghcd
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.2
opogzjuxsyfl3vyc0
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
99wxfnok5lm oy
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
20-F
e1pyxn8quczq 4b6ii
31 Mar 15
Annual report (foreign)
12:00am
424B4
rqsoo24xix67ocmv3riq
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
d79tw2prm3b
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next